CN105462928A - Chinese oral melanoma cell line COMM-1 and establishment method thereof - Google Patents
Chinese oral melanoma cell line COMM-1 and establishment method thereof Download PDFInfo
- Publication number
- CN105462928A CN105462928A CN201510732443.4A CN201510732443A CN105462928A CN 105462928 A CN105462928 A CN 105462928A CN 201510732443 A CN201510732443 A CN 201510732443A CN 105462928 A CN105462928 A CN 105462928A
- Authority
- CN
- China
- Prior art keywords
- cell
- comm
- oral cavity
- chinese
- chinese oral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000001441 melanoma Diseases 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title claims description 26
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 25
- 239000003814 drug Substances 0.000 claims abstract description 10
- 210000000214 mouth Anatomy 0.000 claims description 30
- 238000011160 research Methods 0.000 claims description 14
- 108020004999 messenger RNA Proteins 0.000 claims description 12
- 230000001464 adherent effect Effects 0.000 claims description 8
- 238000001514 detection method Methods 0.000 claims description 6
- 238000003757 reverse transcription PCR Methods 0.000 claims description 5
- 101001005728 Homo sapiens Melanoma-associated antigen 1 Proteins 0.000 claims description 4
- 101001057131 Homo sapiens Melanoma-associated antigen D4 Proteins 0.000 claims description 4
- 101000821885 Homo sapiens Protein S100-B Proteins 0.000 claims description 4
- 102100025050 Melanoma-associated antigen 1 Human genes 0.000 claims description 4
- 108010050345 Microphthalmia-Associated Transcription Factor Proteins 0.000 claims description 4
- 102000013760 Microphthalmia-Associated Transcription Factor Human genes 0.000 claims description 4
- 102100021487 Protein S100-B Human genes 0.000 claims description 4
- 230000001537 neural effect Effects 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 abstract description 116
- 210000000130 stem cell Anatomy 0.000 abstract description 14
- 238000004321 preservation Methods 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 32
- 210000001519 tissue Anatomy 0.000 description 17
- 229960004756 ethanol Drugs 0.000 description 13
- 235000015097 nutrients Nutrition 0.000 description 12
- 230000012010 growth Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 230000029087 digestion Effects 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 101001088883 Homo sapiens Lysine-specific demethylase 5B Proteins 0.000 description 6
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 5
- 102100033247 Lysine-specific demethylase 5B Human genes 0.000 description 5
- 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 5
- 229960000935 dehydrated alcohol Drugs 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- 102100021501 ATP-binding cassette sub-family B member 5 Human genes 0.000 description 4
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 4
- 108020004414 DNA Proteins 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 101000677872 Homo sapiens ATP-binding cassette sub-family B member 5 Proteins 0.000 description 4
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000004069 differentiation Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- 102100022595 Broad substrate specificity ATP-binding cassette transporter ABCG2 Human genes 0.000 description 3
- 108010090306 Member 2 Subfamily G ATP Binding Cassette Transporter Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108091092878 Microsatellite Proteins 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 2
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000004115 adherent culture Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
- 229960005542 ethidium bromide Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000010297 mechanical methods and process Methods 0.000 description 2
- 230000005226 mechanical processes and functions Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- 239000008399 tap water Substances 0.000 description 2
- 235000020679 tap water Nutrition 0.000 description 2
- 230000005748 tumor development Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- NOIIUHRQUVNIDD-UHFFFAOYSA-N 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide Chemical compound C=1C=CC=CC=1CNC(=O)CCNNC(=O)C1=CC=NC=C1 NOIIUHRQUVNIDD-UHFFFAOYSA-N 0.000 description 1
- 102000043966 ABC-type transporter activity proteins Human genes 0.000 description 1
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 102000002734 Collagen Type VI Human genes 0.000 description 1
- 108010043741 Collagen Type VI Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010074870 Histone Demethylases Proteins 0.000 description 1
- 102000008157 Histone Demethylases Human genes 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 108010010995 MART-1 Antigen Proteins 0.000 description 1
- 206010027145 Melanocytic naevus Diseases 0.000 description 1
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 210000004957 autophagosome Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 230000008614 cellular interaction Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 210000004691 chief cell of stomach Anatomy 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 210000001726 chromosome structure Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001476 gene delivery Methods 0.000 description 1
- 238000003205 genotyping method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000008611 intercellular interaction Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HVGQWHMSVYODLJ-GFCCVEGCSA-N melanochrome Natural products CC1(C)Oc2cc3OC(=CC(=O)c3c(O)c2C[C@H]1O)CO HVGQWHMSVYODLJ-GFCCVEGCSA-N 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000000394 mitotic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000005155 neural progenitor cell Anatomy 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 201000005443 oral cavity cancer Diseases 0.000 description 1
- 208000038009 orphan disease Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 229960001957 stomatological preparations Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a Chinese oral melanoma cell line COMM-1. The Chinese oral melanoma cell line COMM-1 is preserved in the China Center for Type Culture Collection, the preservation number is CCTCC:C201586, and the preservation date is June 8th, 2015. The Chinese oral melanoma cell line COMM-1 has the advantages that the Chinese oral melanoma cell line COMM-1 is established, enrichment of tumor stem cells is achieved through the cell line, and a material basis is provided for researching Chinese oral melanoma characters and treatment drug thereof.
Description
Technical field
The invention belongs to cell engineering field, be specifically related to strain Chinese oral cavity K-1735 COMM-1 and an establishment method thereof.
Background technology
The 1.1 melanomatous morbidity in oral cavity and prognosis
Malignant melanoma comes from neural lophocyte, is one of malignant tumour that aggressive is the strongest.Primary oral cavity melanoma is a kind of orphan disease, accounts for malignant tumor of mouth 0.5% and oral cavity biopsy 0.01%.This disease was mainly between 41-60 year, and M-F is 2:1, and patient has no manifest symptom at the ill initial stage, and most of oral cavity melanoma has entered late period when making a definite diagnosis, and visible tumor mass is greater than 4mm.Oral cavity melanoma has a strong impact on patient's sense of taste, and prognosis is poor, and within 5 years, survival rate is only 15-20%.
The foundation of 1.2 clones
Setting up tumor cell line is that research tumour causes the important link in pass.Clone is widely used in each research field of biology.It refers to that directly separation and Culture goes out cell, for follow-up study provides a kind of method of stable cell lines from the tissue of organism.Clone studies the growth of specific cells, metabolism, modulating properties, cell and cell-cell interaction, the effective research material such as the interaction of cell and matrix.The first strain continuous cell line of the mankind is the cervical cancer cell systems (Hela) set up by GeorgeOttoGey laboratory nineteen fifty-one, the foundation of this strain clone is the milestone of human body cell vitro culture, Hela cell advances the process of many research fields such as cell, gene, virus, vaccine, has also deepened the understanding of people to tumour: the reason and process, the screening cancer therapy drug etc. that find the various characteristics of tumour, research tumor development.
Except studying the developing of the characteristic of cell itself and cancer, be also applied to the research field of heredity, immunity, differentiation, growth.In addition, many enterprises can also utilize cell to carry out producing the various factor, albumen etc. both at home and abroad.The widespread use of cell has promoted the flourish of cytobiology.
Original cuiture mainly contains mechanical process and enzyme digestion.Mechanical process mainly utilizes physical shear, is directly shredded by tissue, then these is organized the method for fritter adherent culture.Enzyme digestion is the suitable enzymatic lysis tissue of application thus isolates unicellular, directly the method for suspension or adherent culture.Enzyme for digesting mainly contains: trypsinase, collagenase, pronase, Unidasa etc.
External the building of cancer cells is that difficulty is comparatively large, and one is the pollution that will effectively prevent and remove mycoplasma, mould and bacterium etc.; Two is will ensure that cells survival environment is as serum, substratum, the quality of somatomedin etc.; Three is effectively control fibrocellular growth; Four is to control the going down to posterity and conservation of front 10 generation cells well.Although Moore etc. the seventies establishes HT-144Melanoma in succession, the K-1735s such as RPMI-7951, but its biological characteristics of different melanoma of originating is different, and these clones survival time is long in vitro, its biological characteristics has larger difference compared with solid tumor in body, be difficult to objectively respond the situation of solid tumor in body, therefore, set up the K-1735 of vitro culture, based on energy, research and clinical treatment provide abundant experiment material, for its pathogenesis of discussion, find new treatment means significant.
1.3 the research of melanoma stem cell
In recent years along with the continuous progress to tumor research, tumor stem cell (cancerstemcell is proposed for some recurrent tumors with to radioactivity, chemoresistance, CSC) concept, this theory thinks that tumour cell has heterogeneity, in same tumour, the cell of most cells differentiated has lost Growth and Differentiation potential, only has sub-fraction cell to have the ability of infinite multiplication, differentiation and body outer clone.
Distinguish the basic characteristics of CSC mainly to comprise: one be by tumour transplatation to immunodeficient mouse time, only have little a part of cell to be tumor stem cell in tumour, less cancer cells just can make mouse tumorigenesis.Two is CSC and non-CSC method enrichment of cell by the cell surface marker streaming of uniqueness.Three is that CSC is had self-renewal capacity and can be confirmed by the continuous passage in many generations and transplantation experiments.
Malignant melanoma parental cell suspension culture rear section cell in the unique serum free medium adding somatomedin forms the tumour cell ball of suspension growth, and the melanoma cell surface mark be confirmed in experiment at present is CD20, CD271, JARID1B, ABCB5, ABCG2 etc.CD20 is the surface marker of the malignant melanoma stem cell that the 1st is found, CD20
+melanoma cell subgroup has versatility and Multidirectional Differentiation ability, has external self-renewal capacity and tumorigenicity, can become neural progenitor cell by external evoked.CD271 is low affinity trk C, is also neural spinocellular surface marker, and CD271 is considered to relevant to the peripheroneural Infiltration and metastasis of melanoma cell, and CD271 accounts for greatly the 2.5%-41% of melanoma subgroup.JARID1B is a histone demethylase, has and promotes tumour continuous proliferation, self and versatility.JARID1B low expression or do not express in the normal tissue, and at the strong melanotic nevus tissue abnormalities high expression level of regenerative power, but JARID1B positive cell only accounts for 5%-10%.ATP is in conjunction with boxlike albumen (ATP-bindingcassettetransporter, ABC) be ancient and huge family, it is a class ATP driving pump, ABC family protein hydrolysising ATP generate energy is in order to transport various material, ABCG2 and ABCB5 is considered at the cells with melanoma dryness.
Summary of the invention
The invention provides a kind of Chinese oral cavity K-1735 COMM-1 and establishment method thereof.
First, the invention provides a kind of Chinese oral cavity K-1735 COMM-1, described Chinese oral cavity K-1735 COMM-1 is preserved in China typical culture collection center (CCTCC), its preserving number is CCTCC:C201586, its preservation date is on June 8th, 2015, and preservation address is Wuhan University.
The invention provides the establishment method of a kind of Chinese oral cavity K-1735 COMM-1 further, comprise following concrete steps:
A) tissue explants adherent method is adopted to carry out the original cuiture of oral cavity melanoma cell;
B) carry out Secondary Culture when cell density reaches about 80%, the ratio of going down to posterity is 1:3;
C) the stable cell that goes down to posterity is detected the situation of mrna expression through RT-PCR.
Further, described step c) in, the mRNA K-1735 of detection, neural ridge derived cell tumour antigen mRNA.
Further, described step c) in, the mRNA of detection is Melan-A, TYR, MITF.
The establishment method of described Chinese oral cavity K-1735 COMM-1, step concrete grammar a) is:
1) 1%I Collagen Type VI bag is trained 37 DEG C of static 30min of incubator by culture dish, and cold 1 × PBS washes ware twice, stand-by;
2) configure nutrient solution, to be put in 37 DEG C of thermostat water baths incubation 10 minutes;
3) in super clean bench, take out melanoma tissue, first remove surface fat and epithelium, 75% alcohol disinfecting is no more than 10 seconds, soaks in 1 × PBS, is put in nutrient solution;
4) tissue is cut into fine grained chippings, evenly divides and plant in culture dish, add appropriate nutrient solution, make to organize half to be dipped in nutrient solution;
5) be placed in 37 DEG C, cultivate in the incubator of 5%CO2;
6) appropriate nutrient solution within second day, is supplemented to submergence tissue block slightly;
7) visual cell's growing state suitably changes liquid.
The establishment method of described Chinese oral cavity K-1735 COMM-1, step b) concrete grammar be:
1) abandon nutrient solution, wash once with 1 × PBS, add tryptic digestion;
2) add serum and stop digestion;
3) blow and beat cell, be placed in centrifuge tube, add appropriate nutrient solution piping and druming;
4) centrifugal 1000rpm, 5 minutes;
5) abandon supernatant, add the piping and druming of appropriate nutrient solution and fall apart;
6) cell suspension is added in new culture dish, obtain described Chinese oral cavity K-1735 COMM-1.
Content of the present invention also comprises the purposes of described Chinese oral cavity K-1735 COMM-1 in the melanomatous medicine of research treatment human oral.
Content of the present invention also comprises the purposes of described Chinese oral cavity K-1735 COMM-1 in the melanomatous medicine of preparation human oral.
Content of the present invention also comprises the purposes of described Chinese oral cavity K-1735 COMM-1 in the melanomatous medicine of screening human oral.
Beneficial effect of the present invention is: the present invention establishes Chinese oral cavity K-1735 COMM-1, and achieves the enrichment of tumor stem cell by this clone, for the research melanomatous characteristic in people Chinese oral cavity and medicine thereof provide basic substance.
In order to understand better and implement, describe the present invention in detail below in conjunction with accompanying drawing.
Accompanying drawing explanation
Fig. 1, COMM-1 organize HE to dye
The cellular form of Fig. 2, light Microscopic observation primary cell and COMM-1 continuous cell line.
The ultrastructure figure of COMM-1 cell is observed under Fig. 3, transmission electron microscope.
Fig. 4, sepharose detect the expression of the mRNA of MAGE1, S100B, MITF of COMM-1.
Fig. 5, COMM-1 cell chromosome caryogram microgram (a) and karyomit(e) number statistical graph (b).
The growth curve of Fig. 6, COMM-1 cell
The Clone formation of Fig. 7, COMM-1 cell
The enrichment of tumor stem cell in Fig. 8, melanoma cell COMM-1
Fig. 9, the gene test of tumor stem cell dryness
A kind of Chinese oral cavity K-1735 COMM-1 in the present invention is preserved in China typical culture collection center (CCTCC), and its preserving number is CCTCC:C201586, and its preservation date is on June 8th, 2015, and preservation address is Wuhan University.
Embodiment
The foundation of [embodiment 1] oral cavity K-1735 COMM-1 and CHARACTERISTICS IDENTIFICATION
Material illustrates:
1 clinical samples
This is tested oral cavity tissue used and takes from Zhongshan University's attached brilliance stomatological hospital excision sample.
2 main solution and formula
2.1 cell cultures
1) 10 × PBSBuffer:NaCl80g, KCl2g, Na2HPO411.55g, KH2PO42g, adds the ultrapure water of about 800ml, the abundant stirring and dissolving of magnetic stirring apparatus, and adjust ph to 7.4, is settled to 1L, after autoclave sterilization, and room temperature preservation.
2) foetal calf serum (FBS): purchased from Hyclone company, 4 DEG C of preservations, and substratum is made into suitable proportion.
3) 10 × Trypsin-EDTA (TE): take 1.25gtrypsin, 1.00gEDTA is dissolved in the 1 × PBS of 250ml, filtration sterilization ,-20 DEG C of preservations.Proper concn peptic cell is diluted to 1 × PBSbuffer before using.
4) F12 (DF) substratum: be dissolved in the ultrapure water of 1L, regulate pH value to 7.2, utilize peristaltic pump and 0.22 μm of membrane filtration degerming.4 DEG C of preservations.2 × DF component doubles, and the water yield is constant.DF (-) expression does not add Ampicillin and Kanamycin.
5) mouse tail NTx: during original cuiture, is diluted to the concentration of 1% with 1 × PBS, the ware of each six centimetres adds 1.5mL and cover at the bottom of ware, 37 DEG C of static bags were by 30 minutes.
6) soft agar: softagar adds ultrapure water, autoclave sterilization is made into 0.66% and 1.33%.
7) colchicine: 40 μ g/mL mother liquors, final utilization concentration is 0.2 μ g/mL.
8) melanoma original cuiture liquid: DF+10%FBS.
2.2 nucleic acid electrophoresis
1) 50 × TAE electrophoresis Buffer (pH8.5): add 242gTris in the vial of 1L, 18.6gNa2EDTA2H2O, then adds the secondary water of about 800ml, abundant stirring and dissolving, then the acetic acid adding 57.1ml, fully stir, add secondary water and be settled to 1L, room temperature preservation.Dilute with 1:50 during use.
2) ethidium bromide (EB): storage liquid concentration is 10mg/ml, working concentration is 0.5 μ g/ml.
3) 1% Normal Agarose Gel: take 1g agarose (agarose), add 100ml1 × TAEbuffer, heated and boiled is dissolved completely to agarose, be chilled to about 50 DEG C, add 5 μ lEB storage liquid, make final concentration be 0.5 μ g/ml, shake up rear Casting of gels dull and stereotyped.
3 methods and result:
3.1 human oral cancer melanochrome organize HE to dye
1) 10% formalin or 4%PFA fixing port cavity tissue spend the night;
2) automatic dehydration instrument dewaters: 70% ethanol 2 hours, 80% ethanol 2 hours, 95% ethanol 30 minutes, 95% ethanol 30 minutes, dehydrated alcohol 30 minutes, dehydrated alcohol 2 hours, dehydrated alcohol+TO (1:1) 30 minutes, TO30 minute, TO2 hour, TO+ paraffin (1:1) 30 minutes, paraffin 3 hours, paraffin 2 hours.Totally 12 barrels, 16 hours;
3) embedding machine embeds with paraffin, slicing machine is cut into slices;
4) 60 DEG C, tissue is de-cured, dimethylbenzene 5 minutes, dehydrated alcohol 1 minute, 90% ethanol 1 minute, 80% ethanol 1 minute, 70% ethanol 1 minute, distillation washing 4 minutes;
5) Hematorylin liquid dyeing 1-2 minute, tap water 10 minutes, water-soluble eosin stains 2-3 minute;
6) dewater, transparent and mounting: section is added 70% ethanol 30 seconds, 80% ethanol 30 seconds, 90% ethanol 1 minute, dehydrated alcohol 1 minute, dimethylbenzene 5 minutes, finally uses resinene mounting.
Interpretation of result: as shown in Figure 1, COMM-1 organizes HE stained visible black color element knurl, and tumour cell is variform, and as circle, polygon and fusiformis, several cell is mixed to be deposited; Core is not of uniform size, and chromatin enriches, the large and engrain of kernel, and mitosis figures is easily shown in, melanin granule can exist with in tumour cell and interstitial, and part cell is full of melanin granule, is comparatively serious change.
The foundation of 3.2 human oral K-1735 COMM-1 and morphological observation
3.2.1 cell primary is cultivated and Secondary Culture
Tissue explants adherent method is adopted to cultivate the little block organization shredded, within 5th day, cell climbs out of from tissue block, the visible more fibroblastic growth of process of growth, this research adopts gradient digestion and scrapes division removes inoblast, after repeatedly going down to posterity, treat that inoblast ratio declines gradually, melanoma cell propagation is accelerated, become purer clone, called after COMM-1 cell.So far, COMM-1 cell has gone down to posterity more than 50 times, and cell state is stablized.
Interpretation of result: as shown in Figure 2, under light microscopic, visible COMM-1 cell is variform, and from polygon, fusiformis to circle, cell size differs, and most cell caryoplasm ratio is large, and kernel is many and clear, and mitotic division is many.It is agglomerate layer-by-layer growth that cell covers with culture dish, forms clone not of uniform size.Adherent property is poor, 5 days confluent culture wares, and the ratio of going down to posterity is 1:3.
3.2.2COMM-1 cell ultrastructure
1) inoculating cell is in 6cm culture dish, and cell covers with rear 1xTE and digests cell dispersion;
2) FBS stops digestion, adds perfect medium, the centrifugal 5min of 900r/min;
3) cell mass is fixed through 2.5% glutaraldehyde osmic acid, embedding, ultrathin section(ing), and dyeing, at electric Microscopic observation.
Interpretation of result: as shown in Figure 3, transmission electron microscope observing COMM-1 cellular form visible cell has abundant first antenna projection, and cell golgi body is to exocytosis vesicle, and this is vigorous relevant with cellular metabolism.Can be observed golgi body, rrna, endoplasmic reticulum and autophagosome in cell, nucleus is atypia, and have monokaryon, double-core, kernel is not of uniform size, out-of-shape, and be distributed with the melanin granule that film holds around golgi body, plastosome is numerous.Cell tracking is not tight, loose distribution.
3.2.3COMM-1 the qualification of the significant molecule of cell
3.2.3.1COMM-1 the extraction of cell RNA
1) to take the logarithm cell in vegetative period, abandon nutrient solution, in culture dish, add 1mlTrizol, complete to lysis with pipettor piping and druming, liquid is drawn to 1.5ml without in enzyme centrifuge tube;
2) room temperature is placed and within 5 minutes, is made nucleic acid-protein mixture be separated completely, 4 DEG C, and centrifugal 10 minutes of 12000xg, gets supernatant;
3) often use 1mlTrizol to add chloroform 0.2ml, violent jolting 15s, room temperature leaves standstill 3min and makes it layering, 4 DEG C, centrifugal 15 minutes of 12000xg;
4) the upper strata aqueous phase of≤50% is carefully transferred to another 1.5ml without in the clean centrifuge tube of enzyme;
5) often use 1mlTrizol to add 0.5ml Virahol, mix gently, room temperature leaves standstill 10 minutes, 4 DEG C, centrifugal 10 minutes of 12000xg;
6) abandon supernatant, add without enzyme 75% ethanol 1ml along wall, mix gently;
7) 4 DEG C, centrifugal 5 minutes of 7500xg, abandons supernatant, is inverted by 1.5ml centrifuge tube, to exhaust remaining ethanol, dry with the micropipet of 100 μ l, precipitation be dissolved in 20 ~ 40 μ l without in RNase water;
8) get 1 μ l, measure A260nm and A280nm with ultraviolet spectrophotometer (Nanodrop), RNA concentration (μ g/ml)=A260nm × 40 × extension rate; Purity represents with A260/A280 ratio, and reach 1.8-2.0 and can be used for experiment ,-80 DEG C save backup.
3.2.3.2RT-PCR reverse transcription reaction (by TOYOBOReverTraAce-α-test kit specification sheets operation)
1) be sequentially added in PCR reaction tubes:
Total serum IgE 1 μ l (600ng)
10pmol/LOigo(dT)5μl
RNaseFreeH2O6μl
2) ice bath 1min after 65 DEG C of effect 5min, puts and adds on ice:
3) arrange PCR instrument, 42 DEG C, 60min, 99 DEG C, 5min, 4 DEG C, hold, put-20 DEG C and save backup.
3.2.3.3PCR (by the operation of TOYOBOKOD-Plus-test kit specification sheets)
1) be sequentially added in PCR pipe:
2) add successively in PCR pipe
Different primers is according to settings such as various annealing temperature, cycle number, extension times.
Interpretation of result: adopt sepharose to detect the mrna expression situation of MAGE1, S100B, MITF in COMM-1, result as shown in Figure 4.RT-PCR detects COMM-1 and amplifies MAGE1 object fragment 418bp, S100B object fragment 203bp.
3.2.4COMM-1 DNA fingerprint qualification
STR (shorttandemrepeat, STR), also known as microsatellite DNA (microsatelliteDNA), is the DNA polymorphism locus that a class extensively exists in human genome.It forms core sequence by 2-6 base pair, arranges in tandem sequence repeats.Str locus site length is generally between 100-300bp, because DNA fragmentation length between individuality or DNA sequence dna difference form height polymorphism, in gene delivery process, follow the heredity of Mendelian's codominance mode, may be used for proving whether this research cultured cells comes institute by its patient.Get corrective surgery resection organization and cultivate the COMM-1 cell in 14 generations and deliver to Zhongshan University verification centre of forensic medicine extraction DNA, carry out Analysis and Identification, result
As shown in table 1.
Table 1COMM-1 tissue and cell STR genotyping result
COMM-1 organizes | COMM-1 cell |
D19S433 | 13,14.2 | 13,14.2 |
D5S818 | 11,12 | 11,12 |
D21S11 | 29,32.2 | 29,32.2 6 --> |
D18S51 | 13 | 13 |
D6S1043 | 13 | 13 |
D3S1358 | 17 | 17 |
D13S317 | 8,11 | 8,11 |
D7S820 | 8,11 | 8,11 |
D16S539 | 9 | 9 |
CSF1P0 | 10,11 | 10,11 |
Penta D | 9 | 9 |
Amel | X | X |
Vwa | 16 | 16 |
D8S1179 | 10,15 | 10,15 |
TPOX | 8,11 | 8,11 |
Penta E | 12,21 | 12,21 |
TH01 | 7,10 | 7,10 |
D12S391 | 21 | 21 |
D2S1338 | 19,24 | 19,24 |
FGA | 18,21 | 18,21 |
Interpretation of result: analyze 20 sites respectively to COMM-1 tissue block and cell, comprise an individual character chromosomal foci and 19 non-sex chromosome sites, all STR are all completely the same, can judge that this tissue and cell are same source.
3.2.5 chromosome karyotype analysis
1) be in logarithmic phase COMM-1 and change to nutrient solution containing colchicine (0.2 μ g/mL), cultivate 2 hours;
2) discard supernatant, 1 × PBS washes ware once, discards 1 × PBS, trypsin digestion and cell;
3), after FBS stops digestion, centrifugal 5 minutes of 1000rpm, removes supernatant;
4) the KCL solution (0.075M) adding preheating 37 DEG C processes 30 minutes (different cell stage is different);
5) add 1mL stationary liquid (methyl alcohol: acetic acid=3:1, now with the current), dispel and beat, centrifugal 5 minutes of 1000rpm, discard supernatant, add Fresh fixative, dispel, effect 20-30 minute, centrifugal 5 minutes of 1000rpm, abandons supernatant, adds 0.5mL stationary liquid, make cell suspension again;
6) drip cell suspension 40cm place above slide glass slide (steeping in 30% ethanol, 4 DEG C of refrigerator precoolings), and dispel immediately, spirit lamp is dried;
7) Gimsa stoste: 1 × PBS=1:9 dyes 20 minutes, and tap water rinses.Result as shown in Figure 6.
Interpretation of result: as shown in Fig. 5 a, 5b, karyomit(e) display is abnormal, and its number all has distribution at 41 to 84, and from 40 to 84 setting 10 intervals, result display 46 to 48 karyomit(e)s are maximum, are similar to diploid.Chromosomal dysploidy is the instable performance of tumorgenesis, except chromosome number differs, also there are the abnormal conditions such as deletion, inversion, repetition and transposition in chromosome structure, these can cause some restructuring of gene, lose the gene being unfavorable for tumor development.
The biological characteristics of 3.3COMM-1 cell
3.3.1 cell counting detects cell growth curve and the doubling time of COMM-1 cell
1) the COMM-1 cell of taking the logarithm vegetative period, is inoculated in 24 orifice plates with the cell concn in 10000/ml/ hole;
2) every 24h counting once, carries out cell counting after 1% trysinization, continuous counter 6 days;
3) with every day cell density average for ordinate zou, incubation time is X-coordinate, draw cell growth curve.Result as shown in Figure 7.
4) by the following formulae discovery doubling time.
TD=tlog2/(logNt-logN0)
(TD: doubling time; T: incubation time: Nt: cultivate the cell count after t hour; N0: postvaccinal cell count)
Interpretation of result: this experiment have detected the growth curve of COMM-1 cell as shown in Figure 7, under the culture condition of DF+10%FBS, first four days propagation slowly, the 5th day starts fast breeding to cell, and the doubling time of COMM-1 cell is 104.43 hours.
3.3.2COMM-1 the detection of clonality
1) cell of logarithmic phase is digested, counting, resuspended;
2) get 300,500 cells in six orifice plates, add nutrient solution DF+10%FBS;
3) liquid feeding after a week;
5), after 10 days, by violet staining, take pictures, counting clone number;
Interpretation of result: as shown in Figure 7, the cultural method that experiment adopts plate clone to be formed, 300 and 500 cells are planted respectively in six orifice plates, the clone counting diameter afterwards and be greater than 200 microns for 10 days, A375 is owing to being the more clone of passage number, and cell strain is more stable, and clonality is strong, 300 and 500 cells the cloning efficiency of six orifice plates be respectively 59% and 43.27%, COMM-1 be then 8% and 8.06%.
The enrichment of tumor stem cell and CHARACTERISTICS IDENTIFICATION in 3.4COMM-1
3.4.1 serum free suspension cultivates the tumor stem cell in enrichment COMM-1 clone
1) attached cell of logarithmic phase is digested, counting;
2) re-suspended cell inoculating according to the ratio of 3.5 × 105/6cm ware, adds 4mlDF+8F nutrient solution, Continuous Observation;
3) treat that sacculus cell grows to the 7th day, piping and druming sacculus, 40 micron screen are filtered and are collected sacculus, and 400rpm, 10min are centrifugal, abandon waste liquid;
4) add TE and be placed in 37 DEG C of water-bath digestion 5min, Ti termination reactions;
5) the centrifugal receipts cell of 400g, 10min;
6) count, inoculating cell is in culture dish.
Interpretation of result: as shown in Figure 8, in adherent cell, add serum-free cell culture medium DF+8F, originally Growth of Cells is slack-off, and within second day, nearly 5-10% cell is no longer adherent, forms similar spherical suspending cell; Within 4th day, some cell visible forms fine and close cell cluster, and form becomes circle; Within 6th day, cell is constantly bred, and formed the clone that diameter is greater than 200 microns, size is more even, cell is finer and close, edge is comparatively neat, and refractivity is comparatively strong, but along with incubation time elongated, sacculus cell still keeps adhered state, carry out sacculus to go down to posterity when cell is no longer bred, Continuous Observation finds that s-generation sacculus cell is suspension growth, loses adherent proterties, sacculus form is finer and close than the first-generation, and form is more stable.
3.4.2COMM-1 sacculus stem cell markers detects
1) treat that sacculus cell grows to the 7th day, piping and druming sacculus, 40 micron screen are filtered and are collected sacculus, and 400rpm, 10min are centrifugal, abandon waste liquid;
2) add TE and be placed in 37 DEG C of water-bath digestion 5min, Ti termination reactions;
3) the centrifugal receipts cell of 400g, 10min
4) extract RNA and carry out RT-PCR detection;
Interpretation of result: the mRNA that COMM-1 sacculus cell and attached cell carry out stem cell markers Oct4, ABCB5, CD20, CD271, KDM5B, ABCG2 is detected by the method for RT-PCR, as shown in Figure 9, the mrna expression level of COMM-1 sacculus stem cell gene KDM5B, ABCB5, Oct4 is higher than attached cell, adherent COMM-1 cell by the special certain density of serum-free medium process is described, the cell side group with melanoma stem cell properties can be enriched to.
Above content is in conjunction with concrete preferred implementation further description made for the present invention, can not assert that specific embodiment of the invention is confined to these explanations.For general technical staff of the technical field of the invention, without departing from the inventive concept of the premise, its framework form can be flexible and changeable, can subseries product.Just make some simple deduction or replace, all should be considered as belonging to the scope of patent protection that the present invention is determined by submitted to claims.
Claims (7)
1. a Chinese oral cavity K-1735 COMM-1, described Chinese oral cavity K-1735 COMM-1 is preserved in China typical culture collection center, and its preserving number is CCTCC:C201586.
2. the establishment method of Chinese oral cavity K-1735 COMM-1 according to claim 1, comprises following concrete steps:
A) tissue explants adherent method is adopted to carry out the original cuiture of oral cavity melanoma cell;
B) carry out Secondary Culture when cell density reaches about 80%, the ratio of going down to posterity is 1:3;
C) the stable cell that goes down to posterity is detected the situation of mrna expression through RT-PCR.
3. method according to claim 2, is characterized in that, described step c) in, the mRNA K-1735 of detection, neural ridge derived cell tumour antigen mRNA.
4. method according to claim 2, is characterized in that, described step c) in, the mRNA of detection is MAGE1, S100B, MITF.
5. the purposes of Chinese oral cavity K-1735 COMM-1 according to claim 1 in the melanomatous medicine of research treatment human oral.
6. the purposes of Chinese oral cavity K-1735 COMM-1 according to claim 1 in the melanomatous medicine of preparation human oral.
7. the purposes of Chinese oral cavity K-1735 COMM-1 according to claim 1 in the melanomatous medicine of screening human oral.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510732443.4A CN105462928B (en) | 2015-10-30 | 2015-10-30 | A kind of Chinese oral cavity K-1735 COMM-1 and its method for building up |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510732443.4A CN105462928B (en) | 2015-10-30 | 2015-10-30 | A kind of Chinese oral cavity K-1735 COMM-1 and its method for building up |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105462928A true CN105462928A (en) | 2016-04-06 |
CN105462928B CN105462928B (en) | 2019-04-02 |
Family
ID=55601089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510732443.4A Active CN105462928B (en) | 2015-10-30 | 2015-10-30 | A kind of Chinese oral cavity K-1735 COMM-1 and its method for building up |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105462928B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113201494A (en) * | 2021-04-30 | 2021-08-03 | 上海交通大学医学院附属第九人民医院 | Mucosal melanoma cell and application thereof |
CN113817777A (en) * | 2021-10-27 | 2021-12-21 | 上海交通大学医学院附属第九人民医院 | Congenital giant black nevus benign tumor cell line from human and construction method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102067828A (en) * | 2009-11-24 | 2011-05-25 | 上海市肿瘤研究所 | Highly metastatic model of human melanoma, cell subline, creation methods, and dynamic detection of metastasis |
CN102911915A (en) * | 2012-08-24 | 2013-02-06 | 中山大学 | Chinese tongue squamous cancer cell line (CTSC-1) and establishing method thereof |
-
2015
- 2015-10-30 CN CN201510732443.4A patent/CN105462928B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102067828A (en) * | 2009-11-24 | 2011-05-25 | 上海市肿瘤研究所 | Highly metastatic model of human melanoma, cell subline, creation methods, and dynamic detection of metastasis |
CN102911915A (en) * | 2012-08-24 | 2013-02-06 | 中山大学 | Chinese tongue squamous cancer cell line (CTSC-1) and establishing method thereof |
Non-Patent Citations (8)
Title |
---|
KUO-WEI CHANG ET AL.: "Establishment and characterization of an oral melanoma cell line (ME)", 《ORAL ONCOLOGY》 * |
SILVIA V.LOURENCO ET AL.: "Establishment and Characterization of an Oral Mucosal", 《AM J DERMATOPATHOL》 * |
余元勋等: "《中国医学分子微量元素学》", 30 November 2009 * |
刘毅: "《皮肤肿瘤治疗学》", 31 July 2012 * |
吕世静等: "《临床免疫学检验》", 31 August 2015 * |
吴尚辉等: "黑色素瘤细胞系HME1的建立及其生物学特性分析", 《中南大学学报(医学版)》 * |
祝和成等: "8株人黑色素瘤细胞系的建立及其生物学特性研究", 《中国病理生理杂志》 * |
鄂征等: "《医学组织工程技术与临床应用》", 31 May 2003 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113201494A (en) * | 2021-04-30 | 2021-08-03 | 上海交通大学医学院附属第九人民医院 | Mucosal melanoma cell and application thereof |
CN113817777A (en) * | 2021-10-27 | 2021-12-21 | 上海交通大学医学院附属第九人民医院 | Congenital giant black nevus benign tumor cell line from human and construction method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN105462928B (en) | 2019-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103451148B (en) | People's normal bronchial epithelial cell and primary separation and Culture thereof and Secondary Culture method and purposes | |
CN106520772A (en) | sgRNA and vector pair for orientated knockout of Nrf2 gene in human hepatocyte and application | |
CN103881975B (en) | Human Prostate Cancer Cells and primary separation and Culture thereof and Secondary Culture method and purposes | |
CN102911915A (en) | Chinese tongue squamous cancer cell line (CTSC-1) and establishing method thereof | |
CN103849602A (en) | Bovine testicle cell line as well as establishment method and application thereof | |
CN104928250A (en) | Immortalized dairy cow mammary epithelial cell line, construction method and applications thereof | |
CN105462928A (en) | Chinese oral melanoma cell line COMM-1 and establishment method thereof | |
CN110106150A (en) | A kind of preparation method and application of synovial sarcoma cells system hSS-005R | |
CN102978154A (en) | Primary culture method for simultaneously separating skin fibroblasts and epidermis cells of Inner mongolia white cashmere goat | |
CN106479981B (en) | A kind of people's Endometrial carcinoma cell line and its method for building up | |
CN104694532A (en) | Extracting method of RNA of rubber tree powdery mildew | |
CN109666643A (en) | One plant of cervical intraepithelial neoplasia (CIN) cell line and application thereof containing sequestered HPV18 | |
CN103756966A (en) | Chinese tongue squamous epithelial cell carcinoma cell line CTSC-2 and establishment method thereof | |
CN106047815A (en) | Esophageal cancer cell line and application thereof | |
CN104419676A (en) | Construction of down's syndrome cell model and cell bank of down's syndrome cell by employing hTERT gene recombination | |
CN115161285B (en) | Immortalized Holstein male calf small intestine epithelial cell line and construction method and application thereof | |
CN110172448A (en) | A kind of synovial sarcoma cells system hSS-005R and its progeny cell system | |
CN102392073A (en) | Analysis method for activity of mismatch repair of zebra fish embryo DNA and application thereof | |
CN102028956A (en) | Application of BTG2 (B Cell Translocation Gene 2) in preparing medicament for inhibiting cancer transfer | |
CN104419677A (en) | Construction of trisomy 18 syndrome cell model and cell bank thereof by hTERT transgenosis | |
CN104419684A (en) | Construction of 18-trisomy syndrome cell model and cell bank of 18-trisomy syndrome cell by SV40LT gene transfection | |
CN104419682A (en) | Construction of trisomy 21 syndrome cell model and cell bank thereof by using recombined SV40LT and hTERT genes | |
CN117431204A (en) | Method for culturing goat pox virus by goat kidney suspension cells | |
CN111996169A (en) | Gastric cancer cell line with high transfer potential and establishment method and application thereof | |
CN104419669A (en) | Building of klinefelter syndrome cell model and cell bank of klinefelter syndrome cell by virtue of recombinant SV40 gene |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
OL01 | Intention to license declared |